PRO044

· BioMarin Pharmaceutical

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PRO044, covering 2015-04-09 to 2017-12-08. Get the full timeline:

Most recent: Clinical Trial Update: Open Label, Extension Study of PRO044 in Duchenne Muscular Dystrophy (DMD) [Phase 2]